ID

17724

Description

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist; ODM derived from: https://clinicaltrials.gov/show/NCT00643045

Lien

https://clinicaltrials.gov/show/NCT00643045

Mots-clés

Versions (1)
  1. 30/09/2016 30/09/2016 -
Téléchargé le

30 septembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Idiopathic Parkinson's Disease NCT00643045

Anglais

Eligibility Idiopathic Parkinson's Disease NCT00643045

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with a diagnosis of idiopathic parkinson's disease of less than 5 years duration, and a hoehn and yahr stage of i to iii,
Description

Parkinson Disease disease length | Hoehn and Yahr grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0872146
UMLS CUI [2]
C0451215
who were receiving treatment with a single dopamine agonist at a stable dose for at least 4 weeks prior to visit 1 (screening).
Description

Dopamine Agonist Single Dose Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0178601
UMLS CUI [1,2]
C0205171
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0205360
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with medical conditions and/or taking concomitant medications that would have put them at risk, interfered with the study evaluations, or made them unable to complete the requirements of the study;
Description

medical condition Resulting in Patients At risk | Pharmaceutical Preparations Resulting in Patients At risk | medical condition Interferes with Evaluation | Pharmaceutical Preparations Interfere with Evaluation | medical condition Protocol Compliance Unable | Pharmaceutical Preparations Protocol Compliance Unable

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0332294
UMLS CUI [1,3]
C0030705
UMLS CUI [1,4]
C1444641
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332294
UMLS CUI [2,3]
C0030705
UMLS CUI [2,4]
C1444641
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0220825
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0220825
UMLS CUI [5,1]
C3843040
UMLS CUI [5,2]
C0525058
UMLS CUI [5,3]
C1299582
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0525058
UMLS CUI [6,3]
C1299582
patients with a diagnosis or recent history of substance abuse,
Description

Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
a history of psychosis,
Description

Psychotic Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0033975
who were depressed,
Description

depressed

Type de données

boolean

Alias
UMLS CUI [1]
C0497307
had evidence of dementia or cognitive dysfunction,
Description

Dementia Evidence of | Impaired cognition Evidence of

Type de données

boolean

Alias
UMLS CUI [1,1]
C0497327
UMLS CUI [1,2]
C0332120
UMLS CUI [2,1]
C0338656
UMLS CUI [2,2]
C0332120
or who were experiencing end of dose wearing-off;
Description

Wearing off effect Dose End

Type de données

boolean

Alias
UMLS CUI [1,1]
C1504539
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0444930
female patients of childbearing potential;
Description

Childbearing Potential

Type de données

boolean

Alias
UMLS CUI [1]
C3831118
patients who have previously received safinamide.
Description

safinamide

Type de données

boolean

Alias
UMLS CUI [1]
C1098261
Retour au début de la page

Similar models

Eligibility Idiopathic Parkinson's Disease NCT00643045

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease disease length | Hoehn and Yahr grades
Item
patients with a diagnosis of idiopathic parkinson's disease of less than 5 years duration, and a hoehn and yahr stage of i to iii,
boolean
C0030567 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0451215 (UMLS CUI [2])
Dopamine Agonist Single Dose Stable
Item
who were receiving treatment with a single dopamine agonist at a stable dose for at least 4 weeks prior to visit 1 (screening).
boolean
C0178601 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
medical condition Resulting in Patients At risk | Pharmaceutical Preparations Resulting in Patients At risk | medical condition Interferes with Evaluation | Pharmaceutical Preparations Interfere with Evaluation | medical condition Protocol Compliance Unable | Pharmaceutical Preparations Protocol Compliance Unable
Item
patients with medical conditions and/or taking concomitant medications that would have put them at risk, interfered with the study evaluations, or made them unable to complete the requirements of the study;
boolean
C3843040 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C1444641 (UMLS CUI [1,4])
C0013227 (UMLS CUI [2,1])
C0332294 (UMLS CUI [2,2])
C0030705 (UMLS CUI [2,3])
C1444641 (UMLS CUI [2,4])
C3843040 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0220825 (UMLS CUI [3,3])
C0013227 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0220825 (UMLS CUI [4,3])
C3843040 (UMLS CUI [5,1])
C0525058 (UMLS CUI [5,2])
C1299582 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C0525058 (UMLS CUI [6,2])
C1299582 (UMLS CUI [6,3])
Substance Use Disorders
Item
patients with a diagnosis or recent history of substance abuse,
boolean
C0038586 (UMLS CUI [1])
Psychotic Disorder
Item
a history of psychosis,
boolean
C0033975 (UMLS CUI [1])
depressed
Item
who were depressed,
boolean
C0497307 (UMLS CUI [1])
Dementia Evidence of | Impaired cognition Evidence of
Item
had evidence of dementia or cognitive dysfunction,
boolean
C0497327 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0338656 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
Wearing off effect Dose End
Item
or who were experiencing end of dose wearing-off;
boolean
C1504539 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,3])
Childbearing Potential
Item
female patients of childbearing potential;
boolean
C3831118 (UMLS CUI [1])
safinamide
Item
patients who have previously received safinamide.
boolean
C1098261 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial